Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VEGFR-2-IN-17 (Compound 15a) is a highly potent inhibitor of Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2), with an IC50 value of 67.25 nM. This compound exhibits significant antitumor properties [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | VEGFR-2-IN-17 (Compound 15a) is a highly potent inhibitor of Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2), with an IC50 value of 67.25 nM. This compound exhibits significant antitumor properties [1]. |
In vitro | VEGFR-2-IN-17 (Compound 15a) exhibits antiproliferative effects, demonstrating IC50 values of 34.59 ± 2.82 μM in HepG2 cells, 30.28 ± 2.56 μM in PC3 cells, 47.10 ± 3.59 μM in MCF-7 cells, and 250.33 ± 2.51 μM in WI-38 cells, reflecting its efficacy against these cells [1]. |
Molecular Weight | 375.81 |
Formula | C21H14ClN3O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VEGFR-2-IN-17 inhibitor inhibit